Loading company…
Nuevolution develops Chemetics®, a technology for small molecule lead discovery, with a focus on oncology and chronic inflammatory diseases.
Founded in 2001 and based in Copenhagen, Denmark, Nuevolution is a biopharmaceutical company developing Chemetics® for small molecule lead discovery. Its research focuses on treatments for oncology and chronic inflammatory diseases.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in